We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Drug development support services.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Drug development support services - List of Manufacturers, Suppliers, Companies and Products

Drug development support services Product List

1～4 item / All 4 items

Displayed results
Ohsugi Biopharma Consulting Co., Ltd. Business Introduction

Ohsugi Biopharma Consulting Co., Ltd. Business Introduction

For consulting in pharmaceutical development, please feel free to contact us!

Ohsugi BioPharma Consulting Co., Ltd. is a company primarily engaged in pharmaceutical development support services. We provide consulting services in five areas: drug discovery research, CMC development, regenerative medicine, clinical development, and business development, with consultants who are well-versed in the fundamental research of biopharmaceuticals and the CMC development/quality assurance of both low molecular weight drugs and biopharmaceuticals/regenerative medicine products, supporting the global development of pharmaceuticals. In addition to this business, we also conduct seminar services and paper writing services. [Business Activities] ■ Pharmaceutical Development Support Services ■ Seminar Services ■ Paper Writing Services *For more details, please refer to our catalog or feel free to contact us.

  • Other Consulting Services
  • Product Development

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Pharmaceutical development support services

Pharmaceutical development support services

We will meet the needs for genome and multi-omics analysis in clinical trials. We will also meet the needs for the development of in vitro diagnostic drugs.

Our company provides pharmaceutical development support services. In our genetic analysis services for drug development, we offer a one-stop solution for investigating measurement systems, constructing lab assays, and conducting genetic analyses under a quality assurance system in clinical trials. Additionally, in our development and application support services for in vitro diagnostic drugs, we assist in the development of in vitro diagnostic drugs from the exploration of biomarkers targeting genes to the development and marketing of measurement kits. **Features of Genetic Analysis Services for Drug Development** - Establishment of a system for providing genome analysis services at domestic labs - Support for the analysis of various clinical samples such as tissues and blood - Proposals tailored to testing purposes from multiple platforms, including sequencing, digital PCR, nCounter, and multi-omics analysis **Features of Development and Application Support Services for In Vitro Diagnostic Drugs** - Kit development for in vitro diagnostic drugs (such as companion diagnostics) - Support for foreign manufacturers of in vitro diagnostic drugs and advanced medical devices (such as program medical devices) in Japan as MAH (Marketing Authorization Holder) or DMAH (Designated Marketing Authorization Holder) - Measurement using kits that have received manufacturing and marketing approval as a health inspection laboratory

  • Other Nucleic Acid/DNA Research
  • Analysis and sequencing services
  • Other Analysis

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Antibody drug development support service "CAMouse"

Antibody drug development support service "CAMouse"

A fully human antibody mouse that ensures the normal development of B cells and directly expresses fully human IgG!

The "CAMouse" is a fully human antibody mouse that directly expresses fully human IgG while ensuring the normal development of B cells in mice. Human immunoglobulin heavy chain and K/λ light chain genes have been introduced, while simultaneously inactivating the endogenous heavy and light chain genes in the mouse. Seventy human immunoglobulin V regions, including 32 VH, 22 VK, and 16 Vλ, have been incorporated, providing a rich diversity of rearrangement. [Technological Advantages] ■ Establishment of efficient transgenic technology for ultra-large genes (>500kb) ■ Development of technology to spatially and temporally control B cell development in the host animal, allowing for the production of fully human IgG all at once. *For more details, please download the PDF or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.